MedPath

Using the value of red blood cell distribution and dividing it by blood level of calcium in people with recent pancreas disease to obtain a value to see how fast the disease worsens and causes death.

Not yet recruiting
Conditions
Acute pancreatitis, unspecified,
Registration Number
CTRI/2023/02/049542
Lead Sponsor
Varsha Janakiramanan
Brief Summary

Acute pancreatitis has a significant incidence rate and the prognosis of this condition depends on early identification of severity for initiation of prompt treatment. Hence, this study uses the ratio of Red cell Distribution width to Serum Calcium, to prognosticate the progression of acute pancreatitis based on BISAP scores and NLR, PLR ratios to aid in the same.



The trend of the ratio would be looked at to act as a predictor of  severity and mortality of acute pancreatitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
128
Inclusion Criteria

18 years old 2.Diagnosed as acute pancreatitis based on: 1.Clinical presentation with acute persistent abdominal pain 2.Serum amylase exceeding 3 times the upper limit of normal (100 IU/L) 3.Characteristic findings on abdominal ultrasonography and/or computed tomography At least 2/3.

Exclusion Criteria
  • Acute coronary syndrome 2.
  • Congestive cardiac failure 3.
  • Acute pulmonary embolism 4.
  • Cerebrovascular accident 5.
  • Malignancy 6.
  • Chronic kidney disease 7.
  • Chronic liver disease 8.
  • Recent transfusion history 9.
  • Pregnancy 10.
  • Anemia (Hb <10g/dl).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To predict the severity and mortality in patients with acute pancreatitis using RDW to serumFebruary 2024 to July 2024
calcium ratio.February 2024 to July 2024
Secondary Outcome Measures
NameTimeMethod
To prognosticate the severity and mortality of acute pancreatitis with the BISAP score (Blood urea nitrogen, Impairedmental status, SIRS, Age, Pleural Effusion), Neutrophil to Lymphocyte (NLR) ratio, Platelet to Lymphocyte Ratio (PLR) ratio.

Trial Locations

Locations (1)

Kasturba Hospital, Manipal

🇮🇳

Udupi, KARNATAKA, India

Kasturba Hospital, Manipal
🇮🇳Udupi, KARNATAKA, India
Varsha Janakiramanan
Principal investigator
9108768709
varshajr@rocketmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.